Enlivex Therapeutics Ltd (ENLV) — Net Asset Quality Index
Enlivex Therapeutics Ltd (ENLV) has a Net Asset Quality Index of 83.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ILA20.94 Million minus total liabilities of ILA3.46 Million yields net assets of ILA17.48 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read ENLV total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Enlivex Therapeutics Ltd Net Asset Quality Index Over Time (2012–2024)
This chart shows how Enlivex Therapeutics Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the index stands at 83.5%, representing net assets of ILA17.48 Million against total assets of ILA20.94 Million ILA. For live market cap and overall valuation, see Enlivex Therapeutics Ltd (ENLV) total market value.
Annual Net Asset Quality Index for Enlivex Therapeutics Ltd (2012–2024)
The table below presents the year-by-year Net Asset Quality Index for Enlivex Therapeutics Ltd from 2012 to 2024, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Enlivex Therapeutics Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (ILA) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 85.2% | ILA23.59 Million | ILA27.69 Million | ILA4.10 Million | ▲ +3.5 pp |
| 2023 | 81.7% | ILA30.08 Million | ILA36.83 Million | ILA6.75 Million | ▼ -2.4 pp |
| 2022 | 84.0% | ILA56.84 Million | ILA67.64 Million | ILA10.80 Million | ▼ -5.3 pp |
| 2021 | 89.4% | ILA85.04 Million | ILA95.15 Million | ILA10.11 Million | ▲ +1.4 pp |
| 2020 | 87.9% | ILA35.49 Million | ILA40.36 Million | ILA4.87 Million | ▲ +23.7 pp |
| 2019 | 64.2% | ILA11.28 Million | ILA17.56 Million | ILA6.28 Million | ▼ -23.7 pp |
| 2018 | 88.0% | ILA9.71 Million | ILA11.03 Million | ILA1.33 Million | ▲ +0.7 pp |
| 2017 | 87.3% | ILA3.16 Million | ILA3.62 Million | ILA460.00K | ▲ +5.5 pp |
| 2016 | 81.8% | ILA8.70 Million | ILA10.63 Million | ILA1.93 Million | ▼ -5.6 pp |
| 2015 | 87.4% | ILA17.93 Million | ILA20.52 Million | ILA2.58 Million | ▼ -5.7 pp |
| 2014 | 93.1% | ILA30.67 Million | ILA32.95 Million | ILA2.28 Million | ▼ -4.6 pp |
| 2013 | 97.7% | ILA5.55 Million | ILA5.69 Million | ILA131.00K | ▲ +49.6 pp |
| 2012 | 48.1% | ILA75.00K | ILA156.00K | ILA81.00K | — |